Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients

NCT05870956 · clinicaltrials.gov ↗

COMPLETED

Status

1798

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Nintedanib

Sponsor

Boehringer Ingelheim